Changes in activated protein C resistance during normal pregnancy - 10/09/11
Abstract |
OBJECTIVE: The objective of this study was to determine the changes in activated protein C resistance that occur during normal pregnancy. STUDY DESIGN: In this cross-sectional study activated protein C was measured in 128 women with normal pregnancies in the first, second, and third trimesters and in nonpregnant control subjects with 24 to 39 women in each group. In addition, factor V, factor VIII, free protein S, and functional protein C were measured and correlated with activated protein C levels. Polymerase chain reaction for factor V Leiden mutation was performed. RESULTS: There was a significant fall in the activity of activated protein C in the second and third trimesters of pregnancy (p < 0.05). This was related to increased factor VIII and decreased free protein S levels (p = 0.002, R2 = 0.20). The prevalence of the factor V Leiden mutation was 7.3%. CONCLUSION: Resistance to activated protein C is increased in the second and third trimesters of pregnancy. This is related to the alterations in other coagulation proteins, a phenomenon normally occurring during pregnancy. (Am J Obstet Gynecol 1997;177:162-9.)
Le texte complet de cet article est disponible en PDF.Keywords : Activated protein C resistance, medical complications of pregnance, thrombophilia
Plan
| ☆ | From the Department of Obstetrics and Gynecologya and the Department of Medicine,b University of Ottawa, and the Department of Pathology, University of Toronto.c |
| ☆☆ | Reprint requests: Peter R. Garner, MD, MSc, Department of Obstetrics and Gynecology, Civic Parkdale Cinic, Room 505, 737 Parkdale Ave., Ottawa, Ontario, Canada K1Y 1S8. |
| ★ | 6/1/81733 |
Vol 177 - N° 1
P. 162-169 - juillet 1997 Retour au numéro
Article précédent
- The paradoxical effect of smoking in preeclamptic pregnancies: Smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction
- Sven Cnattingius, James L. Mills, Jonathan Yuen, Olle Eriksson, Helena Salonen
- Activated protein C resistance and adverse pregnancy outcome
- Siegfried Rotmensch, Marco Liberati, Moshe Mittelmann, Zion Ben-Rafael
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?